<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T12:32:34Z</responseDate>
  <request identifier="oai:figshare.com:article/34027136" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34027136</identifier>
        <datestamp>2026-09-29T17:41:15Z</datestamp>
        <setSpec>category_915</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Effect of HbAA, HbAC, HbAS, HbSS and HbSC on SC by &lt;i&gt;iv&lt;/i&gt;SCAs.&lt;/p&gt;</dc:title>
          <dc:creator>Yasmina Drissi-El Boukili (25138150)</dc:creator>
          <dc:creator>Vera Kühne (7252466)</dc:creator>
          <dc:creator>H. Magloire Natama (25138153)</dc:creator>
          <dc:creator>Pieter Moris (5712428)</dc:creator>
          <dc:creator>Elisabet Tintó-Font (18572506)</dc:creator>
          <dc:creator>Antonia Windkouni Bere (25138156)</dc:creator>
          <dc:creator>Odin Goovaerts (138054)</dc:creator>
          <dc:creator>Pieter Guetens (1804669)</dc:creator>
          <dc:creator>Ana Moreno-Murillo (25138159)</dc:creator>
          <dc:creator>Yarno Valgaerts (25138162)</dc:creator>
          <dc:creator>T. Edwig Traoré (25138165)</dc:creator>
          <dc:creator>D. Florence Ouedraogo (25138168)</dc:creator>
          <dc:creator>Halidou Tinto (257156)</dc:creator>
          <dc:creator>Ann Van de Velde (22056553)</dc:creator>
          <dc:creator>Alfred Cortés (33324)</dc:creator>
          <dc:creator>Guy Caljon (119879)</dc:creator>
          <dc:creator>Anna Rosanas-Urgell (112252)</dc:creator>
          <dc:subject>Physical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>malaria transmission relies</dc:subject>
          <dc:subject>influence parasite growth</dc:subject>
          <dc:subject>infected rbc antigens</dc:subject>
          <dc:subject>sc remains unclear</dc:subject>
          <dc:subject>ex vivo &lt;/</dc:subject>
          <dc:subject>measure sc rates</dc:subject>
          <dc:subject>hbb mutant genotypes</dc:subject>
          <dc:subject>different hbb genotypes</dc:subject>
          <dc:subject>host hemoglobin beta</dc:subject>
          <dc:subject>sc assay (&lt;</dc:subject>
          <dc:subject>plasmodium falciparum &lt;/</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>higher sc rates</dc:subject>
          <dc:subject>sc rates</dc:subject>
          <dc:subject>falciparum &lt;/</dc:subject>
          <dc:subject>sc ).</dc:subject>
          <dc:subject>&gt;) sc</dc:subject>
          <dc:subject>vitro &lt;/</dc:subject>
          <dc:subject>tom &lt;/</dc:subject>
          <dc:subject>iv &lt;/</dc:subject>
          <dc:subject>ev &lt;/</dc:subject>
          <dc:subject>type hbb</dc:subject>
          <dc:subject>sexual conversion</dc:subject>
          <dc:subject>results demonstrate</dc:subject>
          <dc:subject>reporter line</dc:subject>
          <dc:subject>process initiated</dc:subject>
          <dc:subject>nf54 -&lt;</dc:subject>
          <dc:subject>igm responses</dc:subject>
          <dc:subject>humoral immunity</dc:subject>
          <dc:subject>human natural</dc:subject>
          <dc:subject>hbaa ).</dc:subject>
          <dc:subject>genetic factor</dc:subject>
          <dc:subject>flow cytometry</dc:subject>
          <dc:subject>disease outcome</dc:subject>
          <dc:subject>burkina faso</dc:subject>
          <dc:subject>asexual parasites</dc:subject>
          <dc:description>&lt;p&gt;&lt;b&gt;(A)&lt;/b&gt; Experimental design of &lt;i&gt;in vitro&lt;/i&gt; SC assays (&lt;i&gt;iv&lt;/i&gt;SCAs) using the NF54&lt;i&gt;-gexp02-Tom P. falciparum&lt;/i&gt; line. Tightly synchronized schizonts (Generation -1) were allowed to reinvade red blood cells (RBCs) of different HBB genotypes, and ring stages (0-5 hpi) were cultured under non-inducing (+Choline) and inducing (-Choline) conditions. Parasite development was assessed by flow cytometry at 35-40 hpi (Generation 0) and 25-30 hpi/35-40 hpi (Generation 1). SCRs were measured by flow cytometry at 25-30 hpi and 35-40 hpi (Generation 1). SCRs by HBB genotype at 35-40 hpi (Generation 1) in &lt;b&gt;(B)&lt;/b&gt; +Choline cultures and (C) in -Choline cultures. &lt;b&gt;(D)&lt;/b&gt; Proportion of asexual and gametocyte stages and total parasitemia by HBB genotype at 35-40 hpi (Generation 1) in +Choline cultures. &lt;b&gt;(E)&lt;/b&gt; Reticulocytes percentage by HBB genotype. Statistical tests: B, C and E, Beta-binomial GLMs with Bonferroni correction for pairwise comparisons. Significant &lt;i&gt;p&lt;/i&gt;-values are shown as: &lt;i&gt;p&lt;/i&gt; &lt; 0.05*, &lt;i&gt;p&lt;/i&gt; &lt; 0.01**, &lt;i&gt;p&lt;/i&gt; &lt; 0.001***; non-significant &lt;i&gt;p&lt;/i&gt;-values as: ns. Abbreviations: CTRL, control sample; GLMs, Generalized linear models; Hb, hemoglobin; HBB, human hemoglobin beta; Hpi, hours post-invasion; SC, sexual conversion; SCR, sexual conversion rates. Panel A was created in BioRender. Yasmina, &lt;b&gt;D.&lt;/b&gt; (2026) &lt;a href="https://BioRender.com/ew8vbur" target="_blank"&gt;https://BioRender.com/ew8vbur&lt;/a&gt;.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T17:40:42Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.ppat.1014542.g002</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Effect_of_HbAA_HbAC_HbAS_HbSS_and_HbSC_on_SC_by_i_iv_i_SCAs_p_/34027136</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
